In Vitro Activities of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus , S . epidermidis , and Enterococcus faecalis Strains

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

We investigated the activities of telavancin and vancomycin against biofilm-producing Staphylococcus and Enterococcus strains. At clinically attainable concentrations, telavancin was active against bacteria embedded in biofilm (minimal biofilm eradication concentration [MBEC], 0.125 to 2 microg/ml) and inhibited biofilm formation at concentrations below the MIC. Vancomycin did not demonstrate the same activity (MBEC, > or =512 microg/ml) against Staphylococcus aureus and Enterococcus faecalis. Telavancin may have a unique role in biofilm-associated infections.

Knowledge Graph

Similar Paper

In Vitro Activities of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus , S . epidermidis , and Enterococcus faecalis Strains
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activity of Telavancin against Gram-Positive Clinical Isolates Recently Obtained in Europe
Antimicrobial Agents and Chemotherapy 2007.0
In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria
Antimicrobial Agents and Chemotherapy 2008.0
Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activity of Telavancin against a Contemporary Worldwide Collection of Staphylococcus aureus Isolates
Antimicrobial Agents and Chemotherapy 2010.0
Activity of Telavancin against Staphylococcus aureus Strains with Various Vancomycin Susceptibilities in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
Antimicrobial Agents and Chemotherapy 2009.0
Comparative Efficacies of Telavancin and Vancomycin in Preventing Device-Associated Colonization and Infection by Staphylococcus aureus in Rabbits
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Evaluation of the Activities of Telavancin, Cefazolin, and Vancomycin against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus in Peritoneal Dialysate
Antimicrobial Agents and Chemotherapy 2007.0
In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates
Antimicrobial Agents and Chemotherapy 2009.0
Specificity of Induction of the vanA and vanB Operons in Vancomycin-Resistant Enterococci by Telavancin
Antimicrobial Agents and Chemotherapy 2010.0